| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $34,742,503 ) (Continued on the next page) |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156316 | Protein arginine methylation in transcription and RNA metabolism | 000 | 2 | NIH | 1/22/2026 | $400,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R25CA217270 | Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care | 001 | 9 | NIH | 5/4/2026 | $4,800 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R25CA217270 | Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care | 000 | 9 | NIH | 3/25/2026 | $226,709 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R21AI196968 | Molecular Mechanisms Governing Non-canonical miR-146a Biogenesis | 000 | 1 | NIH | 2/5/2026 | $489,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS138604 | High Fidelity Genome Editing for the Correction of MECP2 Mutations and Physiologic Regulation of Expression in Rett Syndrome | 000 | 2 | NIH | 2/25/2026 | $718,682 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DE034794 | Protein Phosphoribosylation: Characterization of a novel protein modification | 000 | 2 | NIH | 3/5/2026 | $178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DK147338 | Tissue Context Matters: How exocrine cells regulate islet function in human pancreas | 001 | 1 | NIH | 4/30/2026 | -$178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DK147338 | Tissue Context Matters: How exocrine cells regulate islet function in human pancreas | 001 | 1 | NIH | 4/30/2026 | $178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DK147338 | Tissue Context Matters: How exocrine cells regulate islet function in human pancreas | 000 | 1 | NIH | 4/29/2026 | $178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DK147504 | Three-Dimensional Spatial and Translational profiling of Stress Response Pathways in Type 1 Diabetes | 001 | 1 | NIH | 4/30/2026 | -$178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DK147504 | Three-Dimensional Spatial and Translational profiling of Stress Response Pathways in Type 1 Diabetes | 001 | 1 | NIH | 4/30/2026 | $178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DK147504 | Three-Dimensional Spatial and Translational profiling of Stress Response Pathways in Type 1 Diabetes | 000 | 1 | NIH | 4/29/2026 | $178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS143106 | Targeting Glioblastoma with Multifunctional Anti-RAGE Oligonucleotides | 000 | 1 | NIH | 5/1/2026 | $548,395 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS132083 | Biological function and regulation of PRMT9 in synapse development | 001 | 3 | NIH | 3/3/2026 | $59,488 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS132083 | Biological function and regulation of PRMT9 in synapse development | 000 | 3 | NIH | 1/23/2026 | $535,402 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL173308 | Novel mechanisms and therapeutics for Tyrosine Kinase Inhibitor-induced Cardiotoxicity | 001 | 2 | NIH | 3/20/2026 | $21,701 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL173308 | Novel mechanisms and therapeutics for Tyrosine Kinase Inhibitor-induced Cardiotoxicity | 000 | 2 | NIH | 2/23/2026 | $687,181 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL171309 | Integrative role of Rps6kb1 in pathological cardiac remodeling | 000 | 3 | NIH | 4/28/2026 | $829,606 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01ES034793 | Early Life Exposure to Endocrine Disrupting Chemicals: Epigenomic and Transcriptomic Networks and RAGE in Liver Disease | 000 | 3 | NIH | 4/10/2026 | $767,661 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01ES033514 | Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort | 000 | 5 | NIH | 4/28/2026 | $608,813 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK134652 | Role of trefoil factor family proteins in beta cell function. | 000 | 4 | NIH | 12/5/2025 | $568,098 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK147557 | Circulating extracellular vesicles as a marker of human Type 1 Diabetes pathogenesis | 000 | 1 | NIH | 4/27/2026 | $2,162,737 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK138665 | Targeting bile acid composition to treat metabolic diseases | 000 | 3 | NIH | 12/18/2025 | $665,898 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK141874 | DYRK1A inhibitors, GLP1 Receptor Agonists and Immunomodulation for Beta Cell Regeneration Therapy in Type 1 Diabetes | 000 | 1 | NIH | 2/16/2026 | $868,670 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK140088 | Epigenetic regulation of genomic stability in beta-cell homeostasis | 000 | 2 | NIH | 3/31/2026 | $622,294 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA292596 | Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia | 001 | 2 | NIH | 3/3/2026 | $738,698 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA292893 | Targeting AMP Synthesis to Overcome Resistance to BH3 Mimetics in Acute Myeloid Leukemia | 000 | 2 | NIH | 2/27/2026 | $713,836 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA307311 | Identifying and characterizing a stimulatory immune checkpoint in macrophage immunosurveillance | 000 | 1 | NIH | 3/27/2026 | $733,864 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296280 | CMV-specific CD19 CAR T cells amplified in vivo using CMV Triplex vaccine for B-NHL | 001 | 2 | NIH | 4/16/2026 | $73,869 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296280 | CMV-specific CD19 CAR T cells amplified in vivo using CMV Triplex vaccine for B-NHL | 000 | 2 | NIH | 12/10/2025 | $664,829 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA303847 | Identifying and targeting cancer immune evasion signals against macrophage surveillance | 000 | 1 | NIH | 5/5/2026 | $694,015 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA297752 | Tumor-Selective Radiosensitization by Targeting Hypoxia in Rectal Cancer | 001 | 2 | NIH | 4/27/2026 | $64,297 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296394 | Targeting mitochondrial RNA methylation in high-risk acute myeloid leukemia | 001 | 2 | NIH | 4/16/2026 | $48,754 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA297752 | Tumor-Selective Radiosensitization by Targeting Hypoxia in Rectal Cancer | 000 | 2 | NIH | 1/8/2026 | $578,672 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296394 | Targeting mitochondrial RNA methylation in high-risk acute myeloid leukemia | 000 | 2 | NIH | 12/10/2025 | $438,788 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA301510 | Discovery and validation of CYP8B1 Inhibitors as probes for targeting Hepatocellular Carcinomas (HCC) | 000 | 2 | NIH | 4/9/2026 | $772,905 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA299039 | The role of IL-6/STAT3 signaling in CIC-DUX4 fusion sarcoma metastasis and immunosuppression | 000 | 2 | NIH | 3/31/2026 | $573,528 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA262258 | Elucidating the Cellular Origins of lung adenocarcinoma | 000 | 4 | NIH | 5/11/2026 | $425,575 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266665 | Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer | 001 | 5 | NIH | 1/28/2026 | $556,363 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266659 | The Novel Role and Mechanism of RBM33 in Leukemogenesis | 003 | 5 | NIH | 4/6/2026 | $473,946 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266659 | The Novel Role and Mechanism of RBM33 in Leukemogenesis | 002 | 5 | NIH | 4/2/2026 | -$473,946 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266659 | The Novel Role and Mechanism of RBM33 in Leukemogenesis | 001 | 5 | NIH | 3/20/2026 | $473,946 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA286160 | Targeting Immune Escape in CML/MPN Transformation | 001 | 3 | NIH | 4/17/2026 | $57,161 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA286160 | Targeting Immune Escape in CML/MPN Transformation | 000 | 3 | NIH | 12/12/2025 | $514,454 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA283171 | Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation | 000 | 2 | NIH | 12/16/2025 | $632,001 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279840 | Okazaki fragment maturation: mutagenesis and cell survival | 000 | 4 | NIH | 3/26/2026 | $547,802 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279595 | Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia | 001 | 3 | NIH | 4/16/2026 | $70,805 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279595 | Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia | 000 | 3 | NIH | 12/15/2025 | $637,252 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA269740 | Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL | 001 | 4 | NIH | 4/17/2026 | $51,967 |
|
